| ALQUITY SICAV - VAM US MICRO CAP GROWTH FUND B CAP USD | RVI USA SMALL/MID CAP | 70,25% | 102,44% | 79,87% | 467,38% |
| ALQUITY SICAV - VAM US MICRO CAP GROWTH FUND A CAP USD | RVI USA SMALL/MID CAP | 70,21% | 102,24% | 79,57% | 465,23% |
| POLAR CAPITAL SMART MOBILITY I USD CAP | RVI TECNOLOGÍA | 70,21% | 65,15% | · | · |
| CARMIGNAC PORTFOLIO TECH SOLUTIONS E EUR ACC | RVI TECNOLOGÍA | 70,19% | · | · | · |
| GOLDMAN SACHS ASIA EQUITY INCOME X CAP USD | RVI ASIA EX-JAPÓN | 70,18% | 118,90% | 67,04% | 160,05% |
| POLAR CAPITAL SMART MOBILITY R EUR CAP | RVI TECNOLOGÍA | 69,91% | 60,62% | · | · |
| NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY HKD A ACC (HEDGED) | RVI TECNOLOGÍA | 69,67% | 198,89% | 118,34% | · |
| PICTET - BIOTECH P EUR | RVI BIOTECNOLOGÍA | 69,62% | 58,34% | 55,72% | 141,92% |
| AB SICAV I-INTERNATIONAL TECHNOLOGY PORTFOLIO S USD | RVI TECNOLOGÍA | 69,59% | · | · | · |
| AB SICAV I-INTERNATIONAL TECHNOLOGY PORTFOLIO S1 EUR | RVI TECNOLOGÍA | 69,35% | 180,18% | 155,20% | 816,56% |
| MIRAE ASSET ESG ASIA SECTOR LEADER EQUITY FUND R EUR HEDGED CAP | RVI ASIA EX-JAPÓN | 69,31% | 88,07% | 40,70% | · |
| PICTET - BIOTECH P DY USD | RVI BIOTECNOLOGÍA | 69,19% | 57,67% | 55,90% | 141,49% |
| PICTET - BIOTECH P USD | RVI BIOTECNOLOGÍA | 69,19% | 57,67% | 55,91% | 141,47% |
| POLAR CAPITAL SMART MOBILITY R USD CAP | RVI TECNOLOGÍA | 69,15% | 61,80% | · | · |
| BNP PARIBAS JAPAN SMALL CAP CLASSIC H EUR CAP | RVI JAPÓN SMALL/MID CAP | 69,03% | 148,44% | 165,34% | 317,98% |
| AB SICAV I-INTERNATIONAL TECHNOLOGY PORTFOLIO I EUR | RVI TECNOLOGÍA | 68,96% | 178,19% | 152,16% | 787,03% |
| MULTIUNITS LUX - AMUNDI STOXX EUROPE 600 BASIC RESOURCES UCITS ETF ACC EUR | RVI MATERIAS PRIMAS | 68,85% | 67,65% | 63,58% | · |
| ALTERNATIVE FUND SICAV-SIF - COBAS CONCENTRATED VALUE FUND P EUR CAP | RVI GLOBAL | 68,62% | 142,73% | 217,33% | · |
| CARMIGNAC PORTFOLIO ASIA DISCOVERY F EUR ACC | RVI EMERGENTES SMALL/MID CAP | 68,43% | 122,71% | 113,95% | 190,38% |
| PICTET - BIOTECH R EUR | RVI BIOTECNOLOGÍA | 68,42% | 55,01% | 50,33% | 125,52% |
| POLAR CAPITAL BIOTECHNOLOGY I GBP DIS HEDGED | RVI BIOTECNOLOGÍA | 68,28% | 78,59% | 78,85% | · |
| AB SICAV I-INTERNATIONAL TECHNOLOGY PORTFOLIO S1 USD | RVI TECNOLOGÍA | 68,07% | 181,20% | 156,11% | 823,69% |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO I SD EUR CAP | RVI EMERGENTES | 68,05% | 99,25% | · | · |
| PICTET - BIOTECH R USD | RVI BIOTECNOLOGÍA | 68,00% | 54,36% | 50,51% | 125,13% |
| CARMIGNAC PORTFOLIO ASIA DISCOVERY FW GBP ACC | RVI EMERGENTES SMALL/MID CAP | 67,89% | 123,11% | 117,26% | 198,66% |
| MIRAE ASSET ESG ASIA SECTOR LEADER EQUITY FUND A EUR HEDGED CAP | RVI ASIA EX-JAPÓN | 67,88% | 83,10% | 35,03% | · |
| FIDELITY FUNDS-ASIAN SPECIAL SITUATIONS I-ACC-EUR | RVI ASIA EX-JAPÓN SMALL/MID CAP | 67,87% | 96,56% | 56,46% | 204,28% |
| JANUS HENDERSON HF - BIOTECHNOLOGY IU2 EUR | RVI BIOTECNOLOGÍA | 67,84% | 68,87% | · | · |
| AB SICAV I-INTERNATIONAL TECHNOLOGY PORTFOLIO I USD | RVI TECNOLOGÍA | 67,71% | 179,26% | 153,13% | 794,17% |
| FIDELITY FUNDS-ASIAN SPECIAL SITUATIONS Y-ACC-EUR | RVI ASIA EX-JAPÓN SMALL/MID CAP | 67,66% | 95,66% | 55,31% | · |
| AB SICAV I-INTERNATIONAL TECHNOLOGY PORTFOLIO A EUR | RVI TECNOLOGÍA | 67,61% | 171,60% | 142,28% | 718,95% |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO I SD GBP CAP | RVI EMERGENTES | 67,60% | 98,61% | · | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO I SD USD CAP | RVI EMERGENTES | 67,60% | 99,77% | · | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO I EUR CAP | RVI EMERGENTES | 67,37% | 97,09% | · | · |
| JANUS HENDERSON HF - BIOTECHNOLOGY IU2 USD | RVI BIOTECNOLOGÍA | 67,35% | 70,24% | 116,21% | · |
| ABRDN SICAV I-EMERGING MARKETS EX CHINA EQUITY FUND A ACC EUR HEDGED | RVI EMERGENTES | 67,30% | 83,61% | 21,88% | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO R EUR CAP | RVI EMERGENTES | 67,25% | 96,98% | · | · |
| GOLDMAN SACHS GREATER CHINA EQUITY R CAP USD | RVI CHINA | 67,21% | 112,75% | 35,83% | · |
| JANUS HENDERSON HF - BIOTECHNOLOGY H2 USD | RVI BIOTECNOLOGÍA | 67,18% | 68,07% | 111,91% | · |
| PRINCIPAL GIF ORIGIN GLOBAL EMERGING MARKETS FUND I USD ACC | RVI EMERGENTES | 67,16% | 113,60% | 71,85% | · |
| JANUS HENDERSON HF - BIOTECHNOLOGY A2 EUR | RVI BIOTECNOLOGÍA | 67,10% | 67,10% | · | · |
| FIDELITY FUNDS-ASIAN SPECIAL SITUATIONS I-ACC-SEK | RVI ASIA EX-JAPÓN SMALL/MID CAP | 67,07% | 95,24% | 56,75% | · |
| CARMIGNAC PORTFOLIO ASIA DISCOVERY A EUR ACC | RVI EMERGENTES SMALL/MID CAP | 67,02% | 117,75% | 105,42% | 165,99% |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO R GBP CAP | RVI EMERGENTES | 67,01% | 96,16% | · | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO I GBP CAP | RVI EMERGENTES | 66,97% | 96,48% | · | · |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO I USD CAP | RVI EMERGENTES | 66,96% | 97,79% | · | · |
| PRINCIPAL GIF ORIGIN GLOBAL EMERGING MARKETS FUND N USD ACC | RVI EMERGENTES | 66,91% | 112,23% | 69,57% | · |
| AB SICAV I-INTERNATIONAL TECHNOLOGY PORTFOLIO A SGD | RVI TECNOLOGÍA | 66,89% | 171,90% | 142,65% | 725,65% |
| AB SICAV I-INTERNATIONAL TECHNOLOGY PORTFOLIO C EUR | RVI TECNOLOGÍA | 66,86% | 167,96% | 136,90% | 683,02% |
| GOLDMAN SACHS EMERGING MARKETS EX-CHINA EQUITY PORTFOLIO R USD CAP | RVI EMERGENTES | 66,86% | 97,49% | · | · |
